# Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris

> **NCT04631250** · NA · COMPLETED · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** 5-Aminolevulinic Acid-Containing Product in Cutaneous Dose Form

## Key facts

- **NCT ID:** NCT04631250
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04631250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04631250, "Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04631250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*